Regulation of ERK2 activity by dynamic S-acylation

Cell Rep. 2023 Sep 26;42(9):113135. doi: 10.1016/j.celrep.2023.113135. Epub 2023 Sep 19.

Abstract

Extracellular signal-regulated kinases (ERK1/2) are key effector proteins of the mitogen-activated protein kinase pathway, choreographing essential processes of cellular physiology. Here, we discover that ERK1/2 are subject to S-acylation, a reversible lipid modification of cysteine residues, at C271/C254. The levels of ERK1/2 S-acylation are modulated by epidermal growth factor (EGF) signaling, mirroring its phosphorylation dynamics, and acylation-deficient ERK2 displays altered phosphorylation patterns. We show that ERK1/2 S-acylation is mediated by "writer" protein acyl transferases (PATs) and "eraser" acyl protein thioesterases (APTs) and that chemical inhibition of either lipid addition or removal alters ERK1/2's EGF-triggered transcriptional program. Finally, in a mouse model of metabolic syndrome, we find that ERK1/2 lipidation levels correlate with alterations in ERK1/2 lipidation writer/eraser expression, solidifying a link between ERK1/2 activity, ERK1/2 lipidation, and organismal health. This study describes how lipidation regulates ERK1/2 and offers insight into the role of dynamic S-acylation in cell signaling more broadly.

Keywords: CP: Molecular biology; chemical biology; kinase signaling; lipidation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acylation
  • Animals
  • Epidermal Growth Factor / pharmacology
  • Extracellular Signal-Regulated MAP Kinases
  • Lipids
  • MAP Kinase Signaling System*
  • Mice
  • Phosphorylation

Substances

  • Epidermal Growth Factor
  • Extracellular Signal-Regulated MAP Kinases
  • Lipids
  • Mapk1 protein, mouse